Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TOG array regulator of axonemal microtubules protein 1 (TOGARAM1) is a microtubule-associated protein that contains multiple TOG (tumor overexpressed gene) domains, which are structurally conserved for tubulin binding and microtubule regulation[1][2]. It is found throughout ciliated eukaryotes and is essential for cilium assembly, structural maintenance, and length regulation by coordinating microtubule polymerization and stabilizing axonemal microtubules, particularly at the ciliary tip and basal body[1][2][5]. Mutations in TOGARAM1 disrupt ciliary structure and function, leading to ciliopathies such as Joubert syndrome (JBTS37) and are implicated in neural tube defects like spina bifida by altering Sonic Hedgehog signaling during embryonic development[3][5]. TOGARAM1 does not currently have known direct drug interactions or applications as a classical therapeutic target, but its dysfunction represents a mechanism in rare genetic and developmental disease[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TOG array regulator of axonemal microtubules protein 1 (TOGARAM1).